Sera Prognostics, Inc. (SERA) Financial Statements
Industry: Medical Laboratories (Services)
In fiscal 2025, Sera Prognostics reported revenue of $81,000, up 5.2% from $77,000 the year before. Net income was -$31.9M (a -39417.3% net margin), or -$0.67 per diluted share. Gross margin was -102.5% and operating margin was -45066.7%. Operating activities generated -$25.6M of cash, leaving -$26.3M of free cash flow. At fiscal year end, Sera Prognostics held $101.9M in total assets against $26.5M in total liabilities, including $3.9M of cash and equivalents.
Open the full interactive Sera Prognostics financials → Quarterly statements, key ratios, valuation history and price charts.
Sera Prognostics Key Stats
| Share Price | $2.04 |
|---|---|
| Market Cap | $103.0M |
| Revenue YoY Growth | +5.2% |
| 52-Week Range | $1.59 – $3.75 |
| Shares Outstanding | 50.5 million (basic, 2026 Q2) |
Sera Prognostics Income Statement
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $82,000 | $268,000 | $306,000 | $77,000 | $81,000 |
| Gross Profit | — | — | — | -$5,000 | -$83,000 |
| Operating Income | -$35.4M | -$45.7M | -$39.8M | -$36.6M | -$36.5M |
| Pre-Tax Income | -$35.0M | -$44.2M | -$36.2M | -$32.9M | -$31.9M |
| Income Tax | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$35.0M | -$44.2M | -$36.2M | -$32.9M | -$31.9M |
| Diluted EPS | -$2.33 | -$1.43 | -$1.16 | -$0.99 | -$0.67 |
Sera Prognostics Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $16,000 | $10,000 | $14,000 | $30,000 |
| Net Income | -$7.8M | -$7.9M | -$8.4M | -$9.1M |
| Diluted EPS | -$0.16 | -$0.17 | -$0.17 | -$0.18 |
Sera Prognostics Balance Sheet
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Cash & Equivalents | $58.9M | $29.9M | $3.9M | $4.0M | $3.9M |
| Current Assets | $110.3M | $90.1M | $61.3M | $47.6M | $40.8M |
| Total Assets | $147.0M | $116.3M | $95.4M | $72.6M | $101.9M |
| Current Liabilities | $8.4M | $15.5M | $24.4M | $24.8M | $24.2M |
| Total Liabilities | $8.5M | $17.4M | $25.3M | $24.8M | $26.5M |
| Shareholders' Equity | $138.6M | $98.9M | $70.2M | $47.8M | $75.4M |
Sera Prognostics Cash Flow Statement
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Cash From Operations | -$31.6M | -$34.6M | -$27.2M | -$14.2M | -$25.6M |
| Cash From Investing | -$82.6M | $5.6M | $438,000 | $11.7M | -$28.5M |
| Cash From Financing | $159.6M | $5,000 | $752,000 | $2.6M | $54.0M |
| Free Cash Flow | -$32.9M | -$35.4M | -$27.3M | -$14.2M | -$26.3M |
Figures from Sera Prognostics' 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Sera Prognostics financials page for every line item.
Sera Prognostics Company Profile
| Ticker | SERA |
|---|---|
| Exchange | Nasdaq |
| Industry | Medical Laboratories (Services) |
| Headquarters | Salt Lake City, Utah |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Emerging growth company |
| SEC CIK | 0001534969 |
Frequently Asked Questions
What was Sera Prognostics' revenue in fiscal 2025?
Sera Prognostics (SERA) reported revenue of $81,000 for fiscal 2025.
What is Sera Prognostics' annual revenue history?
Sera Prognostics' annual revenue by fiscal year: 2021: $82,000; 2022: $268,000; 2023: $306,000; 2024: $77,000; 2025: $81,000.
What was Sera Prognostics' net income in fiscal 2025?
Sera Prognostics reported net income of -$31.9M for fiscal 2025.
What was Sera Prognostics' earnings per share (EPS) in fiscal 2025?
Sera Prognostics' diluted EPS was -$0.67 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Sera Prognostics generate in fiscal 2025?
Sera Prognostics generated -$26.3M of free cash flow in fiscal 2025.
What was Sera Prognostics' revenue last quarter?
In its most recent reported quarter (2026 Q2), Sera Prognostics reported revenue of $30,000.
How many shares of Sera Prognostics are outstanding?
Sera Prognostics reported a weighted average of 50.5 million basic shares outstanding in 2026 Q2.
What is Sera Prognostics' market cap?
Based on its latest closing price, Sera Prognostics (SERA) has a market capitalization of about $103.0M.
When does Sera Prognostics' fiscal year end?
Sera Prognostics' fiscal year end, as registered with the SEC, is December 31.
Where is Sera Prognostics headquartered?
Sera Prognostics lists its business address in Salt Lake City, Utah in its SEC filings.